USANA Health Sciences USNA FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's FX effect on cash?
- USANA Health Sciences (USNA) reported FX effect on cash of $896K in Q1 2026.
- How has USANA Health Sciences's FX effect on cash changed year-over-year?
- USANA Health Sciences's FX effect on cash increased by 24.6% year-over-year, from $719K to $896K.
- What is the long-term trend for USANA Health Sciences's FX effect on cash?
- Over 2 years (2021 to 2025), USANA Health Sciences's FX effect on cash has grown at a 56.5% compound annual growth rate (CAGR), from $2.09M to $5.11M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.